Variant report
Variant | esv275190 |
---|---|
Chromosome Location | chr3:60472410-60477642 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:60476221..60479058-chr3:60482642..60484706,2 | K562 | blood: | |
2 | chr3:60468425..60470651-chr3:60470930..60473335,2 | K562 | blood: | |
3 | chr3:60467604..60470651-chr3:60470930..60473335,3 | K562 | blood: | |
4 | chr3:60475674..60478079-chr3:60479619..60482202,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs415832 | chr3:60472410-60472411 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs571144739 | chr3:60472412-60472413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567845816 | chr3:60472450-60472451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376460748 | chr3:60472456-60472457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1531334 | chr3:60472481-60472482 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs578215510 | chr3:60472483-60472484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115700913 | chr3:60472488-60472489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs74752353 | chr3:60472500-60472501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543481849 | chr3:60472504-60472505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562986833 | chr3:60472521-60472522 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530304938 | chr3:60472537-60472538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542676567 | chr3:60472555-60472556 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs5849369 | chr3:60472583-60472584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs398091486 | chr3:60472585-60472586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373569519 | chr3:60472594-60472595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141645972 | chr3:60472604-60472605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs74621770 | chr3:60472618-60472619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2362888 | chr3:60472650-60472651 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs2362889 | chr3:60472673-60472674 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs410072 | chr3:60472710-60472711 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs114682647 | chr3:60472715-60472716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs77255677 | chr3:60472749-60472750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs409432 | chr3:60472755-60472756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs409440 | chr3:60472765-60472766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2362892 | chr3:60472815-60472816 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs376575878 | chr3:60472876-60472877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1447972 | chr3:60472883-60472884 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs535219300 | chr3:60472907-60472908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs409769 | chr3:60472909-60472910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553248408 | chr3:60472949-60472950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2362894 | chr3:60472970-60472971 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs438501 | chr3:60473010-60473011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4485674 | chr3:60473029-60473030 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs2734352 | chr3:60473033-60473034 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs180745271 | chr3:60473055-60473056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs542639404 | chr3:60473075-60473076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545674366 | chr3:60473083-60473084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs373359213 | chr3:60473087-60473088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572961447 | chr3:60473168-60473169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145845504 | chr3:60473191-60473192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs138737010 | chr3:60473206-60473207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs71313774 | chr3:60473213-60473214 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577787436 | chr3:60473251-60473252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9861820 | chr3:60473265-60473266 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs9824052 | chr3:60473289-60473290 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs530518196 | chr3:60473297-60473298 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs17063274 | chr3:60473310-60473311 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs560874986 | chr3:60473362-60473363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs183670453 | chr3:60473363-60473364 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs17063275 | chr3:60473370-60473371 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Cancer | 18162546 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Mental retardation | 17847001 | CNVD |
Neuroticism | 17667963 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Cancer | 20164920 | CNVD |
Schizophrenia | 23813976 | CNVD |
Autism | 22102821 | CNVD |
Prostate cancer | 19363497 | CNVD |
Malaria | 21533027 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Colorectal cancer | 21518781 | CNVD |
Esophageal cancer | 21518781 | CNVD |
Cancer | 20164919 | CNVD |
Schizophrenia | 20967226 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Gastric cancer | 22315472 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:60472200-60472800 | Enhancers | Fetal Intestine Small | intestine |
2 | chr3:60472400-60473200 | Weak transcription | Fetal Intestine Large | intestine |
3 | chr3:60472800-60473800 | Weak transcription | Fetal Intestine Small | intestine |
4 | chr3:60473200-60473800 | Enhancers | Duodenum Mucosa | Duodenum |
5 | chr3:60473200-60474400 | Enhancers | Fetal Intestine Large | intestine |
6 | chr3:60473400-60473800 | Enhancers | Fetal Heart | heart |
7 | chr3:60473800-60474200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr3:60473800-60474400 | Enhancers | Gastric | stomach |
9 | chr3:60474000-60474200 | Enhancers | Fetal Intestine Small | intestine |